1178 related articles for article (PubMed ID: 17481774)
1. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
2. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
3. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
4. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
5. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
7. RNAi in functional genomics.
Scherr M; Eder M
Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
[TBL] [Abstract][Full Text] [Related]
8. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
Singh SK; Hajeri PB
Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
10. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
Akhtar S
Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
[TBL] [Abstract][Full Text] [Related]
11. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
12. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
13. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
14. Efficient and targeted delivery of siRNA in vivo.
Shim MS; Kwon YJ
FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
[TBL] [Abstract][Full Text] [Related]
15. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
17. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
18. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.
Kishida T; Asada H; Gojo S; Ohashi S; Shin-Ya M; Yasutomi K; Terauchi R; Takahashi KA; Kubo T; Imanishi J; Mazda O
J Gene Med; 2004 Jan; 6(1):105-10. PubMed ID: 14716682
[TBL] [Abstract][Full Text] [Related]
19. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
[TBL] [Abstract][Full Text] [Related]
20. Using RNAi in the clinic.
Dev KK
IDrugs; 2006 Apr; 9(4):279-82. PubMed ID: 16596482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
